Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
Satohiro Matsumoto, Hirosato Mashima Department of Gastroenterology, Saitama Medical Center, Jichi Medical University, Saitama, Japan Abstract: Anti-TNFα drugs have been shown to be effective for maintaining stable remission in patients with Crohn’s disease. However, some problem...
Guardado en:
Autores principales: | Matsumoto S, Mashima H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c95abb24c49043a797850f7a694777c1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical utility of ustekinumab in Crohn’s disease
por: Kotze PG, et al.
Publicado: (2018) -
Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
por: Aline Lissa Okita, et al.
Publicado: (2020) -
Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis
por: Fusun Gediz, et al.
Publicado: (2021) -
A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
por: Byron P. Vaughn
Publicado: (2021) -
Machine learning gene expression predicting model for ustekinumab response in patients with Crohn's disease
por: Manrong He, et al.
Publicado: (2021)